AGT and acute coronary syndrome: Key exclusion criteria in ATHOS-3 included hypersensitivity to Ang II, acute coronary syndrome, aortic stenosis, severe hepatic dysfunction, recent Ang II administration (<6 hours), and concurrent use of more than two vasopressors at the time of randomization.